Why is the rapid tumor marker testing market promising?
Growing demand for early cancer screening
Increased public health awareness and policy promotion have led to an increased demand for convenient and economical early cancer screening methods (such as FOB, PSA).
Adjunct diagnosis and treatment monitoring
Tumor marker testing can assist in cancer diagnosis, prognosis, monitoring treatment effects, and recurrence.
Expansion of POCT and primary care applications
Rapid testing is suitable for non-central laboratory settings such as clinics and physical examination centers, expanding the market scope.
reOpenTest Tumor Marker Testing: Reliable, Convenient, and Comprehensive
Covers common tumor markers
Provides rapid tests for prostate cancer (PSA), colorectal cancer (FOB), liver cancer (AFP), broad-spectrum markers (CEA), etc.
Accurate and reliable results
Employs mature technology, performance is validated, and provides reliable test results.
Simple to operate and fast results
Suitable for rapid screening and auxiliary diagnosis scenarios, no complicated equipment is needed.
Help distributors grow their business
Provide competitive new product lines to help you enter or deepen the oncology diagnostics market.
Our core rapid tumor marker testing products
Prostate-Specific Antigen (PSA) Rapid Test
Used for preliminary screening of prostate cancer, convenient and fast.
View details
Fecal Occult Blood (FOB) Rapid Test (Immunological Method)
Non-invasive detection of occult blood in the stool is an important means for large-scale screening of colorectal cancer (immunological method iFOB/FIT).
View details
Alpha-Fetoprotein (AFP) Rapid Test
Mainly used for the auxiliary diagnosis/monitoring and recurrence warning of primary liver cancer.
View details
Carcinoembryonic Antigen (CEA) Rapid Test
Broad-spectrum tumor marker that can be used for the auxiliary diagnosis, prognosis, and recurrence monitoring of various malignant tumors (such as colorectal cancer, lung cancer, gastric cancer, etc.).
View detailsSeize the tumor detection market and expand your business field
Tumor marker testing is an area of significant clinical importance and huge growth potential in the In Vitro Diagnostics market. By distributing reOpenTest's reliable and convenient rapid test reagents, you can effectively meet the needs of clinicians and physical examination institutions in early cancer screening, auxiliary diagnosis, and monitoring, thereby entering or deepening your business layout in the oncology diagnostics market and obtaining sustainable commercial returns. We will provide you with competitive products and professional support to help you succeed.
Ready to expand your tumor detection product line?
reOpenTest rapid tumor marker test reagents offer you new growth opportunities. Contact us now for product information and cooperation plans.